| BI-3802 |
顺式-2-((6-((5-氯-2-(3,5-二甲基哌嗪-1-基)嘧啶-4-基)氨基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基)氧基)-N-甲基乙酰胺 |
2166387-65-9 |
| CPI-455 Hydrochloride |
CPI-455 Hydrochloride |
2095432-28-1 |
| ADH-503 |
ADH-503;ADH503;ADH 503 |
2055362-74-6 |
| 11-amino- Undecanoic acid, 1,1-dimethylethyl ester |
BOC-11-氨基十一酸 |
220851-29-6 |
| ML318 |
ML318 |
1610516-67-0 |
| 9H-Purine-2-carbonitrile, 6-[(3,5-difluorophenyl)aMino]-9-ethyl- |
1199523-24-4 |
1199523-24-4 |
| 2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide |
化合物NSAH |
1099592-35-4 |
| 2-(4-Chlorophenyl)-5-nitrobenziMidazole, 95% |
2-(4-氯苯基)-6-硝基-1H-苯并[D]咪唑 |
1571-87-5 |
| (2R)-2-({[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}amino)-N-(2,4-difluorophenyl)-2-phenylacetamide |
BL 918 NEW |
2101517-69-3 |
| SC-43 |
SC-43 |
1400989-25-4 |
| 2,6-dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide |
GDC-046;GDC 046 |
1258292-64-6 |
| DIM-C-pPhCO2Me |
DIM-C-pPhCO2Me |
151358-48-4 |
| BCI |
BCI |
1245792-51-1 |
| 1H-Benzimidazole-6-carboxylic acid, 2-[1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]-, methyl ester |
METHYL 2-(1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLATE |
2097938-51-5 |
| MKC8866 |
MKC8866 |
1338934-59-0 |
| Ca2+ channel agonist 1 |
1402821-24-2 |
1402821-24-2 |
| (3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone |
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone |
431996-53-1 |
| 1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile |
1-amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile |
150651-39-1 |
| Benzonitrile, 4-[[(1R,2R)-2-[(3R)-3-aMino-1-piperidinyl]-2,3-dihydro-1H-inden-1-yl]oxy]-3-chloro- |
1333210-07-3 |
1333210-07-3 |
| IWP-O1 |
IWP-O1 |
2074607-48-8 |
